MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The value of preference-based measures of quality of life in people with Parkinson’s: A systematic review

Y. Xin, E. McIntosh (Glasgow, United Kingdom)

Meeting: 2016 International Congress

Abstract Number: 522

Keywords: Aging

Session Information

Date: Monday, June 20, 2016

Session Title: Quality of life/caregiver burden in movement disorders

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To systematically review and assess the use and value of preference-based quality of life (QoL) measures in Parkinson’s.

Background: Preference-based QoL measures are used to generate health utilities in economic evaluations. Such measures are mostly generic, with the advantage of facilitating priority setting across disease areas, however they have often been criticised for being insensitive or failing to capture important aspects of health in specific populations, including people with Parkinson’s, as their QoL may be associated with attributes not valued by those generic measures.

Methods: Ten databases were searched up to July 2015 and studies were included if preference-based values were measured or mapped to from a non-preference based QoL measure and reported in people with Parkinson’s. Study characteristics, the measures used and utility values were extracted to pre-designed forms. Construct validity, responsiveness and reliability of the measures were assessed.

Results: 54 of 2,758 studies were included, of which EQ-5D and PDQ-39/8 were the most frequently used preference-based and Parkinson’s specific QoL measure respectively. The EQ-5D was generally shown to be able to discriminate between different patient groups and was responsive to health changes however the extent to which it exhibited convergent validity and reliability in Parkinson’s was less clear. Four out of five mapping algorithms from PDQ-39/8 to EQ-5D did not use half of the PDQ-39/8 dimensions (4/8), stigma, social support, cognition and communication to map.

Conclusions: Despite the overall validity of EQ-5D in Parkinson’s, the absence of mental health and wellbeing aspects in the mapping algorithms suggest it may be limited in capturing important aspects in Parkinson’s. There is thus potential for misrepresentation of PwP’s values in economic evaluations with the current health care decision making framework. There is scope for the development of methods to value Parkinson’s specific QoL attributes such as those included in the PDQ-39/8.

To cite this abstract in AMA style:

Y. Xin, E. McIntosh. The value of preference-based measures of quality of life in people with Parkinson’s: A systematic review [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/the-value-of-preference-based-measures-of-quality-of-life-in-people-with-parkinsons-a-systematic-review/. Accessed May 14, 2025.
  • Tweet
  • Email
  • Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-value-of-preference-based-measures-of-quality-of-life-in-people-with-parkinsons-a-systematic-review/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley